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Abstract 
This publication describes the first ever comprehensive Quality Assurance program of a linear accelerator to be 
developed and performed in Ghana, West Africa. Sweden Ghana Medical Centre has been operating an Elekta 
synergy Platform Linear accelerator over the past years. The QA programs, results and performance evaluations are 
presented and analyzed over a twenty (20) month operational period. The checks include daily, weekly, monthly, 
and yearly quality assurance procedures as well as patient specific quality assurance in accordance with the centre’s 
policy. The results of the evaluation show reproducibility in all quality assurance procedures with an average photon 
and electron daily radiation output constancy of (-0.8%±1.2) and (-1.38±0.96) of expected values respectively. The 
weekly and monthly radiation output constancy checks had an average deviation of 0.53%±0.4 and a maximum 
deviation of 1.9% for photons and an average of 1.5%±0.4 and maximum of 2.6% for electrons. Yearly dosimetry 
quality assurance was within 0.8% of calibrated values at commissioning whiles safety and mechanical/optical 
checks were functional and within set limits respectively. 
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1. Introduction 
Sweden Ghana Medical Centre (SGMC) is the first and only cancer Center in Ghana and among the very few in 
West Africa to operate a linear accelerator (dual energy photon: 6 and 15 MV and a range of electron beams: 6, 10 
and 15 MeV). The Center covers a full range of cancer specialties and utilizes modern state-of-the- art equipment 
and treatment techniques to provide a 3-dimensional (3D) conformal radiation treatment. With no national or 
regional published quality assurance (QA) guidelines to follow, it sometimes becomes very difficult adopting an 
international protocol that suits our local settings. It should also be noted that it may be unrealistic to carry out some 
of the tests described in international protocols [1, 2, 3, 4] at local centres, either because major investments (human 
or technical resources) are required, or because the parameter being tested is not available, or not in clinical use. It is 
also the responsibility of a qualified medical physicist to apply these recommendations in a suitable manner [5]. The 
delivery of accurate prescribed doses to patients is one of the cardinal objectives of radiotherapy treatment. To 
achieve this, it is imperative that effective and efficient quality control (QC) procedures are put in place in every 
country where radiotherapy machines are operated. The operation of an effective QC checks will ensure that the 
machine characteristics do not deviate significantly from their baseline values acquired at the time of acceptance and 
commissioning. This document is intended to provide Ghanaian and to a larger extend West African radiotherapy 
centers with streamlined Linac procedures for carrying out requisite QA tests to suit our local conditions. Specific 
QA protocols have been adapted from the American Association of Physicists in Medicine Task Group (AAPM TG) 
number 40, AAPM TG-45, AAPM TG-142, the European Society of Therapeutic Radiology and Oncology 
(ESTRO) and Elekta recommended user checks for the Linac at SGMC. 
The success of every radiation therapy crucially depends on the accuracy with which the prescribed dose is 
delivered to the tumor volume; thus the dose delivered to the patient should be kept as close as possible to the 
prescribed dose. AAPM TG-40 recommends that the dose delivered to the patient be within ±5% of the prescribed 
dose [1] and ICRU 50 and 62 (-5%, +7%). Quality Assurance describes programs for checking the performance of 
radiotherapy equipment and for measuring the characteristics of the output from such equipment. It has a common 
basis in that it specifies the method of testing and test equipment, the parameters to be tested and the frequency of 
testing, the responsibilities of different members of staff, the baseline values and tolerances for these values, action 
levels and documentation guidelines. A clinical linear accelerator must in all circumstances function within the very 
narrow tolerances obtained at the time of acceptance testing [6]. It is therefore expected that a QA program designed 
specifically for an institution will meet those standards. For radiation oncology, the QA programs are to maintain the 
quality of patient care. The American College of Radiology (ACR) recommends a QA committee be formed with 
appropriate personnel (e.g., radiation oncologist, physicist, dosimetrist, therapist, engineer and administrator) [7]. 
Annual report should be prepared from individual QAs to include but not limited to dosimetry accuracy, mechanical 
accuracy, safety, imaging and special Procedures. Acceptance Testing Procedure (ATP) Standards are set as 
principles in testing the baseline for future dosimetric measurements in beam performance constancy. This verifies 
that the equipment is mechanically functional and operates within certain tolerances from absolute specified values. 
Three action levels (level1-Inspection, level 2-scheduled and level 3- immediate/stop treatment/corrective actions) 
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are set and followed according to their tolerance. 
2.  Materials and Methods 
The proposed and adopted QA procedure included daily, weekly, monthly, and yearly checks, as well as individual 
treatment verifications. The daily QA includes delivery of 500 MU per photon energy as morning Linac warm-up 
and subsequent recording of photon and electron dosimetric values of the central axis at SSD of 100cm. The weekly 
QA includes measuring photon and electron dosimetric outputs and the wedge factors for photons. The monthly QA 
involves a complete and extensive measurement in terms of dosimetry, mechanical/optical and safety aspects. The 
annual QA includes a larger sampling of monthly QAs, beam characteristics, planned maintenance (PM), and 
analysis of all saved QA worksheet files. The individual treatment verification or “per patient” QA includes 
independent MU Calculations and a final check of all plans after the first treatment fraction according to the data in 
the record and verification system of the Linac. The procedures used are tailored to meet the needs of the department 
using published reports as a guide. All the QA tasks performed with their tolerances are summarized in Table 1. 
Based on all these checks, action levels are setted for all radiation constancy and mechanical checks. 
2.1. Daily QA 
The Linac output is checked on a daily basis prior to the first patient being treated. This test can be broadly 
classified into three groups: beam alignment, dosimetry and safety.  A qualified medical physicist or radiotherapist 
usually performs these daily tests. Elekta recommends [8] that the Linac should be warmed up prior to daily use. A 
deviation of less than 3% is desirable for the dosimetric outputs using appropriate diodes. If any of these parameters 
are out of tolerance, they are reported to the medical physicists and the Linac clinical operation is suspended until 
the problem has been investigated further. With markings on the horizontal and vertical walls, it is ensured that the 
sagittal and lateral lasers align with the centre of the marks. The tolerances are 2 mm (that is ±1 mm) for both sets of 
lasers as well as the check for central axis rotation with collimator. The optical distance indicator (ODI) is also 
check at SSD with a tolerance of 2 mm. The door interlocks and audiovisual monitors are also part of the daily QA. 
The results of the daily check must all be within tolerances before the Linac is passed for clinical use. 
2.2. Weekly QA 
The dosimetric tests are performed with calibrated dosimetry equipment, a phantom and an ionization chamber. 
These tests are performed with a high level of accuracy to ensure that small variations are detected. The weekly test 
begins with the beam and mechanical alignment test, because deviations here can influence the dosimetry outcome. 
The output of the Linac is checked using a calibrated PTW Farmer chamber to ensure that 1 cGy/MU is delivered to 
the isocentre under specific reference conditions. A dose of 100 MU is delivered three times and the dosimeter 
readings are recorded using a PTW UNIDOS webline electrometer. The output in nC/MU is calculated as follows: 
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MUPCFKKKFCalKnCadingmeanMUnCOutput selepolTP /).)(Re()/( ××××××=                        (1) 
Where Cal.F is the calibration factor, (Kpol, Kele and Ks) are the collection efficiency factors and mean Reading is the 
average of the electrometer readings. The phantom correction factor (PCF) is taken as 1.0 for a water equivalent 
phantom. KTP is the temperature and pressure correction factor. Four different gantry angles (0°, 90°, 180°, and 
270°) are chosen for each week’s dosimetry measurements and it is important that the output is within ±3% of the 
reference dose. The wedge factor values are also checked for all photon beams using the same reference conditions. 
2.3. Monthly QA 
Monthly checks involve more extensive checks of the radiation, safety and mechanical parameters. The QA 
procedure includes checks on the mechanical system, the image-forming and image detection system, couch 
accuracy, accuracy of gantry movement, accuracy of lasers, accuracy of cross wires and collimators, light / radiation 
field coincidence, door interlocks, anti-collision devices, optical distance indicator accuracy and emergency stop 
buttons. Table 1. describes an overview of the monthly QC checks performed in accordance with these local QA 
procedures. 
2.4. Annual QA 
Annual QA checks are a scaled down version of the commissioning checks. It is a major QC exercise and is 
intended to validate the treatment unit for another twelve months. It involves the use of water phantoms to measure 
beam profiles and depth dose curves. In addition to yearly recommended QA checks, Planned maintenance checks 
[8] are done to keep the system at correct operating conditions and to make sure that the equipment continues to 
operate for as long as possible without unplanned corrective maintenance. Although clinical users do not do PM, it 
is ensured that those PM programs are fully up to date (6 and 12 monthly PM, 2, 3, 5 and 7 yearly PM performed by 
Elekta engineers and technicians). 
2.5. Individual Patient QA 
Patient QA is an essential part of general QA implementation. Plan printouts should be approved, dated and saved 
by the responsible radiation oncologist, with dose prescription clearly written on the plan. This should also be 
reviewed and signed by a medical physicist prior to first treatment. To reduce errors on the first setup, an 
independent verification of the treatment parameters are made after the first fraction. These include MU check, field 
size check, gantry and collimator check, In vivo dosimetry check, port film check etc. All machine parameters used 
for patient setup should be correct. In addition, independent calculation of the dose at isocenter and Dmax values on 
the central axis for every field is made. When deviations are above the threshold, certain actions are taken. Such as, 
changing the isocenteric depth to radiological equivalent depth in inhomogeneous medium, repositioning of the 
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Dmax point correctly and correct estimate of the percentages of the field size covered with multi leaf collimators 
(MLCs). 
Table 1. QA tasks with tolerances and average deviations from analysis. 
FREQUENCY PROCEDURE TOLERANCE               AVERAGE DEVIATION 
Daily Dosimetry 
Photon and electron output constancy 
Mechanical 
Localizing lasers 
Collimator rotation with central axis 
Optical distance indicator(ODI) 
Safety 
Door interlock 
Audiovisual monitors 
 
±3%                                     -0.8% and -1.38% 
 
2mm/±1mm                          0.2mm 
2mm                                      0.1mm 
2mm                                      0.1mm 
 
Functional                              Functional 
Functional                              Functional 
Weekly Dosimetry 
Photon  and electron output constancy* 
Wedge factor constancy 
Mechanical 
Gantry angle isocenter 
Collimator isocenter 
Beam/field size alignment 
 
±3%                                        0.53% and 1.50% 
  3%                                        0.3% 
 
2mm                                        0.1mm 
2mm                                        0.1mm 
2mm                                        0.2mm 
Monthly Dosimetry 
Photon  and electron output constancy* 
Wedge factor constancy 
Photon  and electron beams flatness constancy 
Photon and electron beams symmetry 
Calibration of daily Output dosimeter 
Mechanical 
Gantry/collimator angle readouts 
Optical distance indicator 
Field size indicators 
Treatment couch position  indicators 
Localizing lasers 
Light and treatment field coincidence 
Light field congruence with Collimator 
Imaging system QA 
Safety 
Emergency off switches 
Door Interlocks 
Anti-collision devices 
Planned maintenance procedures** 
 
±3%                                        0.45% and 1.52% 
3%                                          0.3% 
3%                                          1.0% and  0.5% 
3%                                          1.5% and 1.3% 
3%                                          0.8% and 1.6% 
 
1 degree                                  0.2 degree 
2 mm                                       0.1mm 
2 mm                                       0.1mm 
2mm/1 degree                         0.1mm and 0 degree 
2 mm                                       0.15mm 
2 mm                                       0.7mm 
2 mm                                       0.3mm 
Optimum quality                     Optimum quality 
 
Functional                                Functional 
Functional                                Functional 
Functional                                Functional 
Up to date                                Up to date 
Yearly Dosimetry 
Photon flatness and symmetry 
Electron flatness and symmetry 
Photon/electron output calibration 
Mechanical 
Gantry and treatment table isocenter 
Planned maintenance procedures** 
Safety 
Follow manufacturer’s test procedures** 
 
2%                                            1.0% and 1.3% 
2%                                            0.4% and 1.1% 
2%                                            0.8% 
 
2mm                                         0.5mm 
Up to date                                 Up to date 
 
Functional                                 Functional 
* With different gantry angles    ** Elekta planned maintenance checklist 
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3.  Results 
These results represent the dosimetric, mechanical and safety tests done on the Elekta linear accelerator (photons 
and electrons) at SGMC as well as patient specific QAs. Table 1. shows the average deviations from the tolerance 
values adopted for the QA procedures performed over the 20-month period. As seen from the tables, the daily 
constancy check shows reproducibility and a stable delivery of dosimetric quantity of better than ±3%. For daily 
QA, two action levels were established based on the tolerances. Action level 1 was set for deviations of ±3%, where 
treatment continues but the senior physicist is notified immediately for inspection. For deviations more than ±3%, 
action level 2 was set; where treatment was to be stopped immediately and the problem investigated by the 
responsible senior physicist. The results of the daily check were always within tolerances before the Linac was 
passed for clinical use. 
 
Table 2. Dosimetric deviations of QA task. 
 
4. Discussion 
         
For daily QA tests, those parameters which could seriously affect patient positioning and therefore the registration 
of the radiation field and target volume (lasers, ODI); patient dose (output constancy) and safety (door interlock and 
audiovisual contact) were included. From table 1, all these parameters checked were within the acceptable limits and 
in good working condition. The radiation dosimetry checks are performed with calibrated diodes; hence higher 
deviations expected. Weekly dosimetric QA checks were very similar to the daily but performed with a sensitive 
ionization chamber to confirm the daily radiation outputs. As seen in the figure 1, the variations of weekly photon 
dosimetric QA values over time were within 2% of the ionisation chamber-measured reference value, although there 
appears to be a slight positive trend over time for both energies. With over 98 percent of our patients been treated 
with photons, it is a clear evidence of the fact that there is consistency of dose delivered to patients over the 
 ` Wedge factor Flatness  Symmetry Dosimeter 
Dosimetry Avg 
(%) 
Max 
(%) 
Avg 
(%) 
Max 
(%) 
Avg 
(%) 
Max 
(%) 
Avg 
(%) 
Max 
(%) 
Avg 
(%) 
Max 
(%) 
           Monthly           
Photon 0.45 1.30 1.32 1.8 1.04 1.35 1.52 2.31 0.79 1.88 
Electron 1.52 2.00 N/A 0.50 0.78 1.34 1.92 1.63 2.60 
          Weekly           
Photon 0.53 1.90 0.35 1.85 N/A N/A N/A 
Electron 1.50 2.60 N/A 
Daily            
Photon -0.80  -3.00 N/A N/A N/A N/A 
Electron -1.38 -4.00 
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evaluation period. Monthly photon dosimetric QA values also had similar variations and were within 2% of 
reference value. As expected all weekly mechanical checks were all within tolerance. 
All the tests included in the tables are important for ensuring that the equipment is suitable for high quality and safe 
radiation treatments. As seen in the table 2, the variations of the weekly dosimetric values over time were within 
2.6% of the ionisation chamber-measured reference values, with a slightly upward trend for electrons. Variation of 
gantry angles did not have any dosimetric effect on the outcome of these QA checks. A wedge factor constancy of 
0.35% average was recorded for the photon energies. Collimator and gantry isocenters which could affect dosimetric 
outcome both had an average deviation of 0.1mm from reference values. For monthly we include more refined 
testing of parameters which will either have a smaller impact on the patient (e.g., treatment couch indicators) or 
have lower likelihood of changing over a month (e.g., light and radiation field or beam flatness). Monthly 
measurements over the period show an average percentage difference of 0.45% for the photons and 1.52% for the 
electron beam as compared to the values obtained at commissioning.  The maximum difference between dosimetric 
QA values and reference values is about 1.3% for photon beam and 2% for the electron beam. Values which do not 
follow the normal or expected trends were repeated under the same conditions. The differences as expected were 
mainly due to procedural errors or wrong input data. For the yearly QA checks, one of the dosimetric parameters 
that required monitoring was the beam output, specified as the absorbed dose on the central axis under reference 
conditions. This was to validate the absolute dose calibrations of megavoltage photon and electron beams using the 
International Atomic Energy Agency (IAEA) technical report series (TRS 398) [9]. The deviation was below 
tolerance value with an average deviation of 0.8% from commissioning values. Using IBA OmniPro-ImRT software 
and the MatriXX, the flatness and symmetry of the various beams and energies were obtained using the IEC 
protocols. From Fig.2; (a) is the profile for 6MV photon, (b) for 15MV photon, (c) for 6MeV electron, (d) for 
10MeV electron and (d) for 15MeV electron beam. All the monthly and yearly beam flatness and symmetry were 
within set tolerance values. The less sensitive diodes are used for quick daily checks and were operating within 
prescribed tolerances of 3%. Calibration of daily Output dosimeter was done by comparing dosimeter values with 
the equivalent reading obtained from the calibrated ionisation Chamber. Average deviations of 0.8% and 1.6% were 
obtained for photon and electron dosimeter calibration factors respectively. If the deviation is less than ±3%, no 
action is taken, if the deviation is higher than ±3%, the dose meter is recalibrated. 
A custom built LAS VAGAS QA Phantom was used in analyzing the image forming and detection system. Digital 
images were obtained and the number of holes at every row and columns apart were evaluated using the iView 
software tool. Monthly analysis of all the images produced an optimum image quality. The images were also 
observed for distortions.  
QA for individual Plans had deviations below the defined tolerance value with an average dose deviation at 
isocentre of 2.4% and 1.7% for Doses at maximum depths (Dmax) using an independent MU program. Other 
independent verification of the treatment parameters made before and after the first fraction were within allowable 
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limits. The experimental techniques for performing these QA tests are not discussed in this work, as they are 
described in a number of publications cited. 
Fig. 1. Variation of weekly photon dosimetry over the 20-month period for 6 MV and 15MV 
 
 
 
Fig.2. Sample beam profiles for analyzing symmetry and flatness. 
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5. Conclusion 
The QA procedures were structured to meet the clinical requirement for accuracy; necessary to achieve optimum 
treatment. This quality requires a multidisciplinary team effort, as it is concerned with the reduction of errors and 
uncertainties in every aspect of the radiotherapy process. From this stems the need to perform stringent and regular 
QC checks, in terms of dose accuracy, for the Linac to deliver specific doses to the tumor. For the preparation of this 
manual, it was decided to rely as much as possible on well-known published national and international guidelines [1, 
2, 3, 4] as well as the Elekta recommended checks [8]. The structure of this document was intended to be as general 
as possible (logistically and human resources wise), in order to be easily adapted to the different structures of 
Ghanaian and West African radiotherapy departments. At the same time, this document aimed to introduce a 
reasonable level of uniformity for Linac QA methods throughout Ghana and West Africa. It should be noted that, 
these procedures, however, be considered as recommendations and not as mandatory Checks. The daily, weekly and 
monthly tests discussed here should be adequate to detect any potential problems in the operation of the Linac and 
delivering of accurate prescribed doses. Reproducibility of these procedures over the 20-month period for the Linac, 
as well as the accuracy and repeatability of the treatment plans generation and dose delivery were excellent. 
After analyzing and evaluating the results of all the QA checks done over the 20 month period, it became prudent to 
introduce additional QA checks to the existing document. SGMC radiotherapy policies and procedure manuals were 
also to be reviewed yearly and updated as QA procedures change. An external quality audit team (probably, ESTRO 
equal or the local radiation protection institute (RPI)) is to investigate our local QA protocols and advice 
accordingly. Adherence to the QA outlined is to be followed unless there is demonstrable reason to modify them. 
Parameters which show large deviations from their baseline values should be given special attention and checked 
more frequently. Alternatively, if careful and extended monitoring demonstrates that a parameter does not change, 
or hardly changes at all, then the frequency for monitoring this parameter could be reduced. Although it is difficult 
to recommend how long a parameter should be monitored before decreasing the test frequency.  
It was recommended that the magnitude of any deviations from the reference value were to be recorded for each test, 
rather than simply using a tick/OK to confirm that the test has been carried out and the results lie within the allowed 
tolerance limits. This enables trends to be seen and actions taken before the tolerances are exceeded. Finally, the 
execution of the checks requires the appropriate allocation of time and of human resources, which directly affects 
the daily workload of the treatment machines. Therefore, the quality assurance procedures should be considered as 
an integral part of the machine workload and the required time should be allocated within the normal working hours. 
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